<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVB9" lang="spa" raw_text_char_length="1181" raw_text_md5="eb7e23277533acb3a9c941b66f84b08f" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="76" id="segment-0" start_char="1">
<ORIGINAL_TEXT>El fármaco Aplidin de la gallega PharmaMar, 99% más efectivo contra la Covid</ORIGINAL_TEXT>
<TOKEN end_char="2" id="token-0-0" morph="none" pos="word" start_char="1">El</TOKEN>
<TOKEN end_char="10" id="token-0-1" morph="none" pos="word" start_char="4">fármaco</TOKEN>
<TOKEN end_char="18" id="token-0-2" morph="none" pos="word" start_char="12">Aplidin</TOKEN>
<TOKEN end_char="21" id="token-0-3" morph="none" pos="word" start_char="20">de</TOKEN>
<TOKEN end_char="24" id="token-0-4" morph="none" pos="word" start_char="23">la</TOKEN>
<TOKEN end_char="32" id="token-0-5" morph="none" pos="word" start_char="26">gallega</TOKEN>
<TOKEN end_char="42" id="token-0-6" morph="none" pos="word" start_char="34">PharmaMar</TOKEN>
<TOKEN end_char="43" id="token-0-7" morph="none" pos="punct" start_char="43">,</TOKEN>
<TOKEN end_char="46" id="token-0-8" morph="none" pos="word" start_char="45">99</TOKEN>
<TOKEN end_char="47" id="token-0-9" morph="none" pos="punct" start_char="47">%</TOKEN>
<TOKEN end_char="51" id="token-0-10" morph="none" pos="word" start_char="49">más</TOKEN>
<TOKEN end_char="60" id="token-0-11" morph="none" pos="word" start_char="53">efectivo</TOKEN>
<TOKEN end_char="67" id="token-0-12" morph="none" pos="word" start_char="62">contra</TOKEN>
<TOKEN end_char="70" id="token-0-13" morph="none" pos="word" start_char="69">la</TOKEN>
<TOKEN end_char="76" id="token-0-14" morph="none" pos="word" start_char="72">Covid</TOKEN>
<TRANSLATED_TEXT>PharmaMar gallic drug Aplidin, 99% more effective against Covid</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="246" id="segment-1" start_char="81">
<ORIGINAL_TEXT>La farmacéutica gallega PharmaMar ha confirmado que su nuevo fármaco Aplidin sería cien veces más efectivo contra el coronavirus que el tratamiento usado actualmente.</ORIGINAL_TEXT>
<TOKEN end_char="82" id="token-1-0" morph="none" pos="word" start_char="81">La</TOKEN>
<TOKEN end_char="95" id="token-1-1" morph="none" pos="word" start_char="84">farmacéutica</TOKEN>
<TOKEN end_char="103" id="token-1-2" morph="none" pos="word" start_char="97">gallega</TOKEN>
<TOKEN end_char="113" id="token-1-3" morph="none" pos="word" start_char="105">PharmaMar</TOKEN>
<TOKEN end_char="116" id="token-1-4" morph="none" pos="word" start_char="115">ha</TOKEN>
<TOKEN end_char="127" id="token-1-5" morph="none" pos="word" start_char="118">confirmado</TOKEN>
<TOKEN end_char="131" id="token-1-6" morph="none" pos="word" start_char="129">que</TOKEN>
<TOKEN end_char="134" id="token-1-7" morph="none" pos="word" start_char="133">su</TOKEN>
<TOKEN end_char="140" id="token-1-8" morph="none" pos="word" start_char="136">nuevo</TOKEN>
<TOKEN end_char="148" id="token-1-9" morph="none" pos="word" start_char="142">fármaco</TOKEN>
<TOKEN end_char="156" id="token-1-10" morph="none" pos="word" start_char="150">Aplidin</TOKEN>
<TOKEN end_char="162" id="token-1-11" morph="none" pos="word" start_char="158">sería</TOKEN>
<TOKEN end_char="167" id="token-1-12" morph="none" pos="word" start_char="164">cien</TOKEN>
<TOKEN end_char="173" id="token-1-13" morph="none" pos="word" start_char="169">veces</TOKEN>
<TOKEN end_char="177" id="token-1-14" morph="none" pos="word" start_char="175">más</TOKEN>
<TOKEN end_char="186" id="token-1-15" morph="none" pos="word" start_char="179">efectivo</TOKEN>
<TOKEN end_char="193" id="token-1-16" morph="none" pos="word" start_char="188">contra</TOKEN>
<TOKEN end_char="196" id="token-1-17" morph="none" pos="word" start_char="195">el</TOKEN>
<TOKEN end_char="208" id="token-1-18" morph="none" pos="word" start_char="198">coronavirus</TOKEN>
<TOKEN end_char="212" id="token-1-19" morph="none" pos="word" start_char="210">que</TOKEN>
<TOKEN end_char="215" id="token-1-20" morph="none" pos="word" start_char="214">el</TOKEN>
<TOKEN end_char="227" id="token-1-21" morph="none" pos="word" start_char="217">tratamiento</TOKEN>
<TOKEN end_char="233" id="token-1-22" morph="none" pos="word" start_char="229">usado</TOKEN>
<TOKEN end_char="245" id="token-1-23" morph="none" pos="word" start_char="235">actualmente</TOKEN>
<TOKEN end_char="246" id="token-1-24" morph="none" pos="punct" start_char="246">.</TOKEN>
<TRANSLATED_TEXT>The Welsh pharmaceutical company PharmaMar has confirmed that its new drug Aplidin would be 100 times more effective against coronavirus than the treatment currently used.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="464" id="segment-2" start_char="248">
<ORIGINAL_TEXT>Un equipo de investigadores ha determinado a través de un estudio publicado en la revista Science que el Aplidin, con base de plitidepsina, reduce en un 99% la carga viral de la Covid en comparación con el remdesivir.</ORIGINAL_TEXT>
<TOKEN end_char="249" id="token-2-0" morph="none" pos="word" start_char="248">Un</TOKEN>
<TOKEN end_char="256" id="token-2-1" morph="none" pos="word" start_char="251">equipo</TOKEN>
<TOKEN end_char="259" id="token-2-2" morph="none" pos="word" start_char="258">de</TOKEN>
<TOKEN end_char="274" id="token-2-3" morph="none" pos="word" start_char="261">investigadores</TOKEN>
<TOKEN end_char="277" id="token-2-4" morph="none" pos="word" start_char="276">ha</TOKEN>
<TOKEN end_char="289" id="token-2-5" morph="none" pos="word" start_char="279">determinado</TOKEN>
<TOKEN end_char="291" id="token-2-6" morph="none" pos="word" start_char="291">a</TOKEN>
<TOKEN end_char="298" id="token-2-7" morph="none" pos="word" start_char="293">través</TOKEN>
<TOKEN end_char="301" id="token-2-8" morph="none" pos="word" start_char="300">de</TOKEN>
<TOKEN end_char="304" id="token-2-9" morph="none" pos="word" start_char="303">un</TOKEN>
<TOKEN end_char="312" id="token-2-10" morph="none" pos="word" start_char="306">estudio</TOKEN>
<TOKEN end_char="322" id="token-2-11" morph="none" pos="word" start_char="314">publicado</TOKEN>
<TOKEN end_char="325" id="token-2-12" morph="none" pos="word" start_char="324">en</TOKEN>
<TOKEN end_char="328" id="token-2-13" morph="none" pos="word" start_char="327">la</TOKEN>
<TOKEN end_char="336" id="token-2-14" morph="none" pos="word" start_char="330">revista</TOKEN>
<TOKEN end_char="344" id="token-2-15" morph="none" pos="word" start_char="338">Science</TOKEN>
<TOKEN end_char="348" id="token-2-16" morph="none" pos="word" start_char="346">que</TOKEN>
<TOKEN end_char="351" id="token-2-17" morph="none" pos="word" start_char="350">el</TOKEN>
<TOKEN end_char="359" id="token-2-18" morph="none" pos="word" start_char="353">Aplidin</TOKEN>
<TOKEN end_char="360" id="token-2-19" morph="none" pos="punct" start_char="360">,</TOKEN>
<TOKEN end_char="364" id="token-2-20" morph="none" pos="word" start_char="362">con</TOKEN>
<TOKEN end_char="369" id="token-2-21" morph="none" pos="word" start_char="366">base</TOKEN>
<TOKEN end_char="372" id="token-2-22" morph="none" pos="word" start_char="371">de</TOKEN>
<TOKEN end_char="385" id="token-2-23" morph="none" pos="word" start_char="374">plitidepsina</TOKEN>
<TOKEN end_char="386" id="token-2-24" morph="none" pos="punct" start_char="386">,</TOKEN>
<TOKEN end_char="393" id="token-2-25" morph="none" pos="word" start_char="388">reduce</TOKEN>
<TOKEN end_char="396" id="token-2-26" morph="none" pos="word" start_char="395">en</TOKEN>
<TOKEN end_char="399" id="token-2-27" morph="none" pos="word" start_char="398">un</TOKEN>
<TOKEN end_char="402" id="token-2-28" morph="none" pos="word" start_char="401">99</TOKEN>
<TOKEN end_char="403" id="token-2-29" morph="none" pos="punct" start_char="403">%</TOKEN>
<TOKEN end_char="406" id="token-2-30" morph="none" pos="word" start_char="405">la</TOKEN>
<TOKEN end_char="412" id="token-2-31" morph="none" pos="word" start_char="408">carga</TOKEN>
<TOKEN end_char="418" id="token-2-32" morph="none" pos="word" start_char="414">viral</TOKEN>
<TOKEN end_char="421" id="token-2-33" morph="none" pos="word" start_char="420">de</TOKEN>
<TOKEN end_char="424" id="token-2-34" morph="none" pos="word" start_char="423">la</TOKEN>
<TOKEN end_char="430" id="token-2-35" morph="none" pos="word" start_char="426">Covid</TOKEN>
<TOKEN end_char="433" id="token-2-36" morph="none" pos="word" start_char="432">en</TOKEN>
<TOKEN end_char="445" id="token-2-37" morph="none" pos="word" start_char="435">comparación</TOKEN>
<TOKEN end_char="449" id="token-2-38" morph="none" pos="word" start_char="447">con</TOKEN>
<TOKEN end_char="452" id="token-2-39" morph="none" pos="word" start_char="451">el</TOKEN>
<TOKEN end_char="463" id="token-2-40" morph="none" pos="word" start_char="454">remdesivir</TOKEN>
<TOKEN end_char="464" id="token-2-41" morph="none" pos="punct" start_char="464">.</TOKEN>
<TRANSLATED_TEXT>A team of researchers has determined through a study published in the journal Science that Aplidin, based on plitidepsin, reduces the viral load of Covid by 99% compared to remdesivir.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="549" id="segment-3" start_char="467">
<ORIGINAL_TEXT>El Aplidin es un fármaco concebido inicialmente para tratamientos contra el cáncer.</ORIGINAL_TEXT>
<TOKEN end_char="468" id="token-3-0" morph="none" pos="word" start_char="467">El</TOKEN>
<TOKEN end_char="476" id="token-3-1" morph="none" pos="word" start_char="470">Aplidin</TOKEN>
<TOKEN end_char="479" id="token-3-2" morph="none" pos="word" start_char="478">es</TOKEN>
<TOKEN end_char="482" id="token-3-3" morph="none" pos="word" start_char="481">un</TOKEN>
<TOKEN end_char="490" id="token-3-4" morph="none" pos="word" start_char="484">fármaco</TOKEN>
<TOKEN end_char="500" id="token-3-5" morph="none" pos="word" start_char="492">concebido</TOKEN>
<TOKEN end_char="513" id="token-3-6" morph="none" pos="word" start_char="502">inicialmente</TOKEN>
<TOKEN end_char="518" id="token-3-7" morph="none" pos="word" start_char="515">para</TOKEN>
<TOKEN end_char="531" id="token-3-8" morph="none" pos="word" start_char="520">tratamientos</TOKEN>
<TOKEN end_char="538" id="token-3-9" morph="none" pos="word" start_char="533">contra</TOKEN>
<TOKEN end_char="541" id="token-3-10" morph="none" pos="word" start_char="540">el</TOKEN>
<TOKEN end_char="548" id="token-3-11" morph="none" pos="word" start_char="543">cáncer</TOKEN>
<TOKEN end_char="549" id="token-3-12" morph="none" pos="punct" start_char="549">.</TOKEN>
<TRANSLATED_TEXT>Aplidine is a drug originally intended for cancer treatment.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="725" id="segment-4" start_char="551">
<ORIGINAL_TEXT>Tras este importante estudio, PharmaMar trabaja ya en dar comienzo a la fase 3 del ensayo clínico con el objetivo de poder lanzar al mercado el fármaco a mediados de este año.</ORIGINAL_TEXT>
<TOKEN end_char="554" id="token-4-0" morph="none" pos="word" start_char="551">Tras</TOKEN>
<TOKEN end_char="559" id="token-4-1" morph="none" pos="word" start_char="556">este</TOKEN>
<TOKEN end_char="570" id="token-4-2" morph="none" pos="word" start_char="561">importante</TOKEN>
<TOKEN end_char="578" id="token-4-3" morph="none" pos="word" start_char="572">estudio</TOKEN>
<TOKEN end_char="579" id="token-4-4" morph="none" pos="punct" start_char="579">,</TOKEN>
<TOKEN end_char="589" id="token-4-5" morph="none" pos="word" start_char="581">PharmaMar</TOKEN>
<TOKEN end_char="597" id="token-4-6" morph="none" pos="word" start_char="591">trabaja</TOKEN>
<TOKEN end_char="600" id="token-4-7" morph="none" pos="word" start_char="599">ya</TOKEN>
<TOKEN end_char="603" id="token-4-8" morph="none" pos="word" start_char="602">en</TOKEN>
<TOKEN end_char="607" id="token-4-9" morph="none" pos="word" start_char="605">dar</TOKEN>
<TOKEN end_char="616" id="token-4-10" morph="none" pos="word" start_char="609">comienzo</TOKEN>
<TOKEN end_char="618" id="token-4-11" morph="none" pos="word" start_char="618">a</TOKEN>
<TOKEN end_char="621" id="token-4-12" morph="none" pos="word" start_char="620">la</TOKEN>
<TOKEN end_char="626" id="token-4-13" morph="none" pos="word" start_char="623">fase</TOKEN>
<TOKEN end_char="628" id="token-4-14" morph="none" pos="word" start_char="628">3</TOKEN>
<TOKEN end_char="632" id="token-4-15" morph="none" pos="word" start_char="630">del</TOKEN>
<TOKEN end_char="639" id="token-4-16" morph="none" pos="word" start_char="634">ensayo</TOKEN>
<TOKEN end_char="647" id="token-4-17" morph="none" pos="word" start_char="641">clínico</TOKEN>
<TOKEN end_char="651" id="token-4-18" morph="none" pos="word" start_char="649">con</TOKEN>
<TOKEN end_char="654" id="token-4-19" morph="none" pos="word" start_char="653">el</TOKEN>
<TOKEN end_char="663" id="token-4-20" morph="none" pos="word" start_char="656">objetivo</TOKEN>
<TOKEN end_char="666" id="token-4-21" morph="none" pos="word" start_char="665">de</TOKEN>
<TOKEN end_char="672" id="token-4-22" morph="none" pos="word" start_char="668">poder</TOKEN>
<TOKEN end_char="679" id="token-4-23" morph="none" pos="word" start_char="674">lanzar</TOKEN>
<TOKEN end_char="682" id="token-4-24" morph="none" pos="word" start_char="681">al</TOKEN>
<TOKEN end_char="690" id="token-4-25" morph="none" pos="word" start_char="684">mercado</TOKEN>
<TOKEN end_char="693" id="token-4-26" morph="none" pos="word" start_char="692">el</TOKEN>
<TOKEN end_char="701" id="token-4-27" morph="none" pos="word" start_char="695">fármaco</TOKEN>
<TOKEN end_char="703" id="token-4-28" morph="none" pos="word" start_char="703">a</TOKEN>
<TOKEN end_char="712" id="token-4-29" morph="none" pos="word" start_char="705">mediados</TOKEN>
<TOKEN end_char="715" id="token-4-30" morph="none" pos="word" start_char="714">de</TOKEN>
<TOKEN end_char="720" id="token-4-31" morph="none" pos="word" start_char="717">este</TOKEN>
<TOKEN end_char="724" id="token-4-32" morph="none" pos="word" start_char="722">año</TOKEN>
<TOKEN end_char="725" id="token-4-33" morph="none" pos="punct" start_char="725">.</TOKEN>
<TRANSLATED_TEXT>Following this important study, PharmaMar is already working on starting phase 3 of the clinical trial with the aim of being able to launch the drug on the market by the middle of this year.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="835" id="segment-5" start_char="728">
<ORIGINAL_TEXT>Ya durante el 2020 se pudo comprobar que Aplidin tenía importantes efectos antivirales sobre el Coronavirus.</ORIGINAL_TEXT>
<TOKEN end_char="729" id="token-5-0" morph="none" pos="word" start_char="728">Ya</TOKEN>
<TOKEN end_char="737" id="token-5-1" morph="none" pos="word" start_char="731">durante</TOKEN>
<TOKEN end_char="740" id="token-5-2" morph="none" pos="word" start_char="739">el</TOKEN>
<TOKEN end_char="745" id="token-5-3" morph="none" pos="word" start_char="742">2020</TOKEN>
<TOKEN end_char="748" id="token-5-4" morph="none" pos="word" start_char="747">se</TOKEN>
<TOKEN end_char="753" id="token-5-5" morph="none" pos="word" start_char="750">pudo</TOKEN>
<TOKEN end_char="763" id="token-5-6" morph="none" pos="word" start_char="755">comprobar</TOKEN>
<TOKEN end_char="767" id="token-5-7" morph="none" pos="word" start_char="765">que</TOKEN>
<TOKEN end_char="775" id="token-5-8" morph="none" pos="word" start_char="769">Aplidin</TOKEN>
<TOKEN end_char="781" id="token-5-9" morph="none" pos="word" start_char="777">tenía</TOKEN>
<TOKEN end_char="793" id="token-5-10" morph="none" pos="word" start_char="783">importantes</TOKEN>
<TOKEN end_char="801" id="token-5-11" morph="none" pos="word" start_char="795">efectos</TOKEN>
<TOKEN end_char="813" id="token-5-12" morph="none" pos="word" start_char="803">antivirales</TOKEN>
<TOKEN end_char="819" id="token-5-13" morph="none" pos="word" start_char="815">sobre</TOKEN>
<TOKEN end_char="822" id="token-5-14" morph="none" pos="word" start_char="821">el</TOKEN>
<TOKEN end_char="834" id="token-5-15" morph="none" pos="word" start_char="824">Coronavirus</TOKEN>
<TOKEN end_char="835" id="token-5-16" morph="none" pos="punct" start_char="835">.</TOKEN>
<TRANSLATED_TEXT>As early as 2020, Aplidin was shown to have important antiviral effects on Coronavirus.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="965" id="segment-6" start_char="837">
<ORIGINAL_TEXT>Desde la empresa gallega afirman que, pese a las vacunas, será necesario un tratamiento para hacer frente al virus a largo plazo.</ORIGINAL_TEXT>
<TOKEN end_char="841" id="token-6-0" morph="none" pos="word" start_char="837">Desde</TOKEN>
<TOKEN end_char="844" id="token-6-1" morph="none" pos="word" start_char="843">la</TOKEN>
<TOKEN end_char="852" id="token-6-2" morph="none" pos="word" start_char="846">empresa</TOKEN>
<TOKEN end_char="860" id="token-6-3" morph="none" pos="word" start_char="854">gallega</TOKEN>
<TOKEN end_char="868" id="token-6-4" morph="none" pos="word" start_char="862">afirman</TOKEN>
<TOKEN end_char="872" id="token-6-5" morph="none" pos="word" start_char="870">que</TOKEN>
<TOKEN end_char="873" id="token-6-6" morph="none" pos="punct" start_char="873">,</TOKEN>
<TOKEN end_char="878" id="token-6-7" morph="none" pos="word" start_char="875">pese</TOKEN>
<TOKEN end_char="880" id="token-6-8" morph="none" pos="word" start_char="880">a</TOKEN>
<TOKEN end_char="884" id="token-6-9" morph="none" pos="word" start_char="882">las</TOKEN>
<TOKEN end_char="892" id="token-6-10" morph="none" pos="word" start_char="886">vacunas</TOKEN>
<TOKEN end_char="893" id="token-6-11" morph="none" pos="punct" start_char="893">,</TOKEN>
<TOKEN end_char="898" id="token-6-12" morph="none" pos="word" start_char="895">será</TOKEN>
<TOKEN end_char="908" id="token-6-13" morph="none" pos="word" start_char="900">necesario</TOKEN>
<TOKEN end_char="911" id="token-6-14" morph="none" pos="word" start_char="910">un</TOKEN>
<TOKEN end_char="923" id="token-6-15" morph="none" pos="word" start_char="913">tratamiento</TOKEN>
<TOKEN end_char="928" id="token-6-16" morph="none" pos="word" start_char="925">para</TOKEN>
<TOKEN end_char="934" id="token-6-17" morph="none" pos="word" start_char="930">hacer</TOKEN>
<TOKEN end_char="941" id="token-6-18" morph="none" pos="word" start_char="936">frente</TOKEN>
<TOKEN end_char="944" id="token-6-19" morph="none" pos="word" start_char="943">al</TOKEN>
<TOKEN end_char="950" id="token-6-20" morph="none" pos="word" start_char="946">virus</TOKEN>
<TOKEN end_char="952" id="token-6-21" morph="none" pos="word" start_char="952">a</TOKEN>
<TOKEN end_char="958" id="token-6-22" morph="none" pos="word" start_char="954">largo</TOKEN>
<TOKEN end_char="964" id="token-6-23" morph="none" pos="word" start_char="960">plazo</TOKEN>
<TOKEN end_char="965" id="token-6-24" morph="none" pos="punct" start_char="965">.</TOKEN>
<TRANSLATED_TEXT>The Welsh company claims that despite vaccines, treatment will be needed to deal with the virus in the long term.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1085" id="segment-7" start_char="968">
<ORIGINAL_TEXT>Este estudio de PharmaMar ha hecho que la empresa se dispare en bolsa un 15% y aumente la confianza de los inversores.</ORIGINAL_TEXT>
<TOKEN end_char="971" id="token-7-0" morph="none" pos="word" start_char="968">Este</TOKEN>
<TOKEN end_char="979" id="token-7-1" morph="none" pos="word" start_char="973">estudio</TOKEN>
<TOKEN end_char="982" id="token-7-2" morph="none" pos="word" start_char="981">de</TOKEN>
<TOKEN end_char="992" id="token-7-3" morph="none" pos="word" start_char="984">PharmaMar</TOKEN>
<TOKEN end_char="995" id="token-7-4" morph="none" pos="word" start_char="994">ha</TOKEN>
<TOKEN end_char="1001" id="token-7-5" morph="none" pos="word" start_char="997">hecho</TOKEN>
<TOKEN end_char="1005" id="token-7-6" morph="none" pos="word" start_char="1003">que</TOKEN>
<TOKEN end_char="1008" id="token-7-7" morph="none" pos="word" start_char="1007">la</TOKEN>
<TOKEN end_char="1016" id="token-7-8" morph="none" pos="word" start_char="1010">empresa</TOKEN>
<TOKEN end_char="1019" id="token-7-9" morph="none" pos="word" start_char="1018">se</TOKEN>
<TOKEN end_char="1027" id="token-7-10" morph="none" pos="word" start_char="1021">dispare</TOKEN>
<TOKEN end_char="1030" id="token-7-11" morph="none" pos="word" start_char="1029">en</TOKEN>
<TOKEN end_char="1036" id="token-7-12" morph="none" pos="word" start_char="1032">bolsa</TOKEN>
<TOKEN end_char="1039" id="token-7-13" morph="none" pos="word" start_char="1038">un</TOKEN>
<TOKEN end_char="1042" id="token-7-14" morph="none" pos="word" start_char="1041">15</TOKEN>
<TOKEN end_char="1043" id="token-7-15" morph="none" pos="punct" start_char="1043">%</TOKEN>
<TOKEN end_char="1045" id="token-7-16" morph="none" pos="word" start_char="1045">y</TOKEN>
<TOKEN end_char="1053" id="token-7-17" morph="none" pos="word" start_char="1047">aumente</TOKEN>
<TOKEN end_char="1056" id="token-7-18" morph="none" pos="word" start_char="1055">la</TOKEN>
<TOKEN end_char="1066" id="token-7-19" morph="none" pos="word" start_char="1058">confianza</TOKEN>
<TOKEN end_char="1069" id="token-7-20" morph="none" pos="word" start_char="1068">de</TOKEN>
<TOKEN end_char="1073" id="token-7-21" morph="none" pos="word" start_char="1071">los</TOKEN>
<TOKEN end_char="1084" id="token-7-22" morph="none" pos="word" start_char="1075">inversores</TOKEN>
<TOKEN end_char="1085" id="token-7-23" morph="none" pos="punct" start_char="1085">.</TOKEN>
<TRANSLATED_TEXT>This PharmaMar study has caused the company to burst 15% of the stock market and increase investor confidence.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1177" id="segment-8" start_char="1087">
<ORIGINAL_TEXT>El precio de las acciones se sitúa en 98,50 euros, aunque llegaron a subir hasta 107 euros.</ORIGINAL_TEXT>
<TOKEN end_char="1088" id="token-8-0" morph="none" pos="word" start_char="1087">El</TOKEN>
<TOKEN end_char="1095" id="token-8-1" morph="none" pos="word" start_char="1090">precio</TOKEN>
<TOKEN end_char="1098" id="token-8-2" morph="none" pos="word" start_char="1097">de</TOKEN>
<TOKEN end_char="1102" id="token-8-3" morph="none" pos="word" start_char="1100">las</TOKEN>
<TOKEN end_char="1111" id="token-8-4" morph="none" pos="word" start_char="1104">acciones</TOKEN>
<TOKEN end_char="1114" id="token-8-5" morph="none" pos="word" start_char="1113">se</TOKEN>
<TOKEN end_char="1120" id="token-8-6" morph="none" pos="word" start_char="1116">sitúa</TOKEN>
<TOKEN end_char="1123" id="token-8-7" morph="none" pos="word" start_char="1122">en</TOKEN>
<TOKEN end_char="1129" id="token-8-8" morph="none" pos="unknown" start_char="1125">98,50</TOKEN>
<TOKEN end_char="1135" id="token-8-9" morph="none" pos="word" start_char="1131">euros</TOKEN>
<TOKEN end_char="1136" id="token-8-10" morph="none" pos="punct" start_char="1136">,</TOKEN>
<TOKEN end_char="1143" id="token-8-11" morph="none" pos="word" start_char="1138">aunque</TOKEN>
<TOKEN end_char="1152" id="token-8-12" morph="none" pos="word" start_char="1145">llegaron</TOKEN>
<TOKEN end_char="1154" id="token-8-13" morph="none" pos="word" start_char="1154">a</TOKEN>
<TOKEN end_char="1160" id="token-8-14" morph="none" pos="word" start_char="1156">subir</TOKEN>
<TOKEN end_char="1166" id="token-8-15" morph="none" pos="word" start_char="1162">hasta</TOKEN>
<TOKEN end_char="1170" id="token-8-16" morph="none" pos="word" start_char="1168">107</TOKEN>
<TOKEN end_char="1176" id="token-8-17" morph="none" pos="word" start_char="1172">euros</TOKEN>
<TOKEN end_char="1177" id="token-8-18" morph="none" pos="punct" start_char="1177">.</TOKEN>
<TRANSLATED_TEXT>The price of the shares is set at 98.50 euros, although they went up to 107 euros.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>